MedTech Resources

Company

Neuronetics

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements, plus private placements it reported on Form D.

Public

Listed

STIM

Nasdaq · Neuronetics, Inc.

Public float

$129M

Value of shares held by non-insiders on Jun 30, 2025

Revenue

$149M

Fiscal year ending Dec 31, 2025

Net income

-$39.0M

Fiscal year ending Dec 31, 2025

R&D spending

$6.6M

Fiscal year ending Dec 31, 2025

Cash

$22.1M

As of Sep 30, 2026

Long-term debt

$61.8M

As of Sep 30, 2026

Shares outstanding

77.7M

As of Oct 28, 2026

Capital raised as a public company

Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.

YearIPOStock soldLong-term debtConvertible debt
2025––$10.0M–
2024––$57.5M–
2023––$25.0M–
2021–$81.0M––

Private placements (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Jun 1, 2017Equity$15.0M$15.0M22Rule 506(b)Form D ↗Jun 13, 2017
Apr 24, 2015Equity$34.3M$34.3M23Rule 506(b)Form D ↗May 7, 2015
Nov 21, 2014Options or warrants$9.1M$15.0M23Rule 506(b)Form D ↗Dec 3, 2014
Dec 20, 2012Options or warrants$272K$272K1Rule 506Form D ↗Jan 3, 2013
May 13, 2011Equity$30.0M$30.0M22Rule 506Form D ↗May 23, 2011
Aug 20, 2009Equity$30.0M$30.5M17Rule 506Form D ↗Aug 21, 2009

Company details

From the company's latest Form D.

Legal name
Neuronetics, Inc.
Headquarters
Malvern, Pennsylvania
Incorporated
Delaware over five years before filing
Entity type
Corporation
Revenue range
Decline to Disclose
Industry filed under
Other Health Care

Executives, directors and promoters

As listed on the latest Form D.

  • Cassie HallbergExecutive Officer
  • Anthony PuiExecutive Officer
  • Christopher ThatcherExecutive Officer, Director
  • Greg HarperExecutive Officer
  • Brian FarleyDirector
  • Stephen CampeDirector
  • Peter DonatoExecutive Officer
  • Wilfred JaegerDirector
  • Ron HuntDirector
  • Steve MacKinnonExecutive Officer

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

The investor database is part of the paid tier

For Neuronetics we have 3 shareholders with 5% or more.

It is included for signed-in readers who have credit, along with the daily news digest. Credit is also what pays for AI device summaries.

Latest FDA decisions

The 8 newest of 11 since 2015.

Search the Clearance Tracker

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar

Reports received

31

Received Nov 1, 2025 to Nov 19, 2026

Malfunction reports

1

3.2% of reports

Injury reports

30

97% of reports

Death reports

0

0.0% of reports

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 230100
Jan 240300
Feb 240200
Mar 240700
Apr 240400
May 240100
Jun 240500
Jul 240100
Aug 240000
Sep 240200
Oct 240100
Nov 240800
Dec 240200
Jan 250200
Feb 250300
Mar 250100
Apr 250600
May 2502100
Jun 250800
Jul 250600
Aug 250400
Sep 2501000
Oct 250200
Nov 250200
Dec 250100
Jan 260200
Feb 260500
Mar 260500
Apr 260400
May 260000
Jun 261100
Jul 260500
Aug 260000
Sep 260400
Oct 260100
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.